ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
13 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
johndprent
|
2.9K |
1.0M |
26 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
johndprent
|
2.9K |
1.0M |
7 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
johndprent
|
2.9K |
1.0M |
15 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
johndprent
|
56 |
16K |
26 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
56
|
16K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
johndprent
|
56 |
16K |
47 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
56
|
16K
|
47
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
johndprent
|
56 |
16K |
62 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
56
|
16K
|
62
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
60 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
60
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
9 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
26 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
26
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
36 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
36
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
15 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
15
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
19 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
johndprent
|
80 |
24K |
24 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
24K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
johndprent
|
80 |
24K |
36 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
24K
|
36
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
johndprent
|
80 |
24K |
40 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
24K
|
40
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
johndprent
|
11K |
3.8M |
12 |
18/06/24 |
18/06/24 |
General
|
11K
|
3.8M
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
johndprent
|
110 |
35K |
25 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
110
|
35K
|
25
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
31 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
31
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
johndprent
|
11K |
3.8M |
19 |
17/06/24 |
17/06/24 |
General
|
11K
|
3.8M
|
19
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
johndprent
|
11K |
3.8M |
24 |
17/06/24 |
17/06/24 |
General
|
11K
|
3.8M
|
24
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
johndprent
|
11K |
3.8M |
44 |
17/06/24 |
17/06/24 |
General
|
11K
|
3.8M
|
44
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
7 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
|
|
johndprent
|
82 |
24K |
30 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
82
|
24K
|
30
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
|
|
johndprent
|
82 |
24K |
81 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
82
|
24K
|
81
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
19 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
19
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
38 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
|
|
johndprent
|
82 |
24K |
22 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
82
|
24K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
|
|
johndprent
|
82 |
24K |
49 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
82
|
24K
|
49
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
|
|
johndprent
|
82 |
24K |
47 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
82
|
24K
|
47
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
|
|
johndprent
|
82 |
24K |
60 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
82
|
24K
|
60
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
2 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
johndprent
|
110 |
35K |
11 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
110
|
35K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
johndprent
|
110 |
35K |
10 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
110
|
35K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
johndprent
|
110 |
35K |
41 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
110
|
35K
|
41
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification of cessation of securities - RAC
|
|
johndprent
|
4 |
1.4K |
23 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
4
|
1.4K
|
23
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
25 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
25
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
16 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
16
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
johndprent
|
2.2K |
754K |
7 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
2.2K
|
754K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
johndprent
|
2.2K |
754K |
40 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
2.2K
|
754K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Offer Results
|
|
johndprent
|
35 |
11K |
38 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
35
|
11K
|
38
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
johndprent
|
11K |
3.8M |
26 |
05/06/24 |
05/06/24 |
General
|
11K
|
3.8M
|
26
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
6 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
9 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Is RAC undervalued? the rNPV says...
|
|
johndprent
|
4 |
2.0K |
46 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
4
|
2.0K
|
46
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
johndprent
|
21K |
7.4M |
26 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
21K
|
7.4M
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
johndprent
|
35 |
10K |
24 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
35
|
10K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
johndprent
|
35 |
10K |
26 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
35
|
10K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
johndprent
|
1.0K |
298K |
23 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
1.0K
|
298K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
johndprent
|
1.0K |
298K |
38 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
1.0K
|
298K
|
38
|
|